NOTCH3 and breast cancer: In contrast, NOTCH-3 acts as a tumor suppressor, in human breast cancer, with mutations resulting in elevated tumor proliferation, invasion, angiogenesis, epithelial-to-mesenchymal transition (EMT), and self-renewal of breast cancer stem-like cells [12, 14–20].